Bioxyne Limited (AU:BXN)
ASX:BXN
Australian Market
Holding AU:BXN?
Track your performance easily

Bioxyne Limited (BXN) Income Statement

3 Followers

Bioxyne Limited Income Statement

Last quarter (Q4 2022), Bioxyne Limited's total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Bioxyne Limited's net income was AU$―. See Bioxyne Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19
Total Revenue
-AU$ 2.42MAU$ 2.11MAU$ 2.26MAU$ 2.13M
Cost of Revenue
-AU$ 1.13MAU$ 1.03MAU$ 1.04MAU$ 990.07K
Gross Profit
-AU$ 1.29MAU$ 1.08MAU$ 1.22MAU$ 1.14M
Operating Expense
-AU$ 1.55MAU$ 1.47MAU$ 1.73MAU$ 2.62M
Operating Income
-AU$ -257.62KAU$ -385.37KAU$ -514.20KAU$ -1.47M
Net Non Operating Interest Income Expense
-AU$ 14.81KAU$ 16.98KAU$ 33.03KAU$ 41.09K
Other Income Expense
-AU$ -43.76KAU$ -94.70KAU$ -111.93KAU$ 165.83K
Pretax Income
-AU$ -236.51KAU$ -425.73KAU$ -593.10KAU$ -1.27M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-AU$ -236.51KAU$ -425.73KAU$ -593.10KAU$ -1.27M
Basic EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01
Diluted EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01
Basic Average Shares
-AU$ 640.15MAU$ 640.15MAU$ 640.15MAU$ 640.15M
Diluted Average Shares
-AU$ 640.15MAU$ 640.15MAU$ 640.15MAU$ 640.15M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-----
Net Income From Continuing And Discontinued Operation
-AU$ -236.51KAU$ -425.73KAU$ -593.10KAU$ -1.27M
Normalized Income
-AU$ -103.85KAU$ -271.30KAU$ -380.63KAU$ -1.27M
Interest Expense
-AU$ 582.00AU$ 1.68KAU$ 7.03K-
EBIT
-AU$ -235.93KAU$ -424.04KAU$ -586.06KAU$ -1.47M
EBITDA
-AU$ -185.87KAU$ -336.78KAU$ -514.00KAU$ -1.47M
Currency in AUD

Bioxyne Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis